$10.27
12.67%
NYSE, Oct 16, 04:19 pm EDT. Closed.
ISIN
US37611X1000
Symbol
DNA
Sector
Industry

Ginkgo Bioworks Target price 2026 - Analyst rating & recommendation

Ginkgo Bioworks Classifications & Recommendation

Hold
30%
Sell
70%

Ginkgo Bioworks Price Target

Target Price $7.14
Price $10.27
Deviation
Number of Estimates 3
3 Analysts have issued a price target Ginkgo Bioworks 2027 . The average Ginkgo Bioworks target price is $7.14. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 0 Analysts recommend Ginkgo Bioworks to buy, 3 to hold and 7 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ginkgo Bioworks stock has an average upside potential 2027 of . Most analysts recommend the Ginkgo Bioworks stock at Sale.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ ??? ???
??? ???
EBITDA Margin ??? ???
??? ???
Net Margin ??? ???
??? ???

4 Analysts have issued a sales forecast Ginkgo Bioworks 2026 . The average Ginkgo Bioworks sales estimate is

. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .

This results in the following potential growth metrics:

Revenue Estimates

2025 $170m 25.05%
2026
2027
2028

2 Analysts have issued an Ginkgo Bioworks EBITDA forecast 2026. The average Ginkgo Bioworks EBITDA estimate is

. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-251m 40.31%
2026
2027
2028

EBITDA Margin

2025 -147.44% 20.35%
2026
2027
2028

3 Ginkgo Bioworks Analysts have issued a net profit forecast 2026. The average Ginkgo Bioworks net profit estimate is

. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-313m 42.83%
2026
2027
2028

Net Margin

2025 -183.80% 23.71%
2026
2027
2028

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ ??? ???
??? ???
P/E ???
EV/Sales ???

3 Analysts have issued a Ginkgo Bioworks forecast for earnings per share. The average Ginkgo Bioworks EPS is

. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-5.64 46.49%
2026
2027
2028

P/E ratio

Current -2.19 6.84%
2026
2027
2028

Based on analysts' sales estimates for 2026, the Ginkgo Bioworks stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.48 145.07%
2026
2027
2028

P/S ratio

Current 6.18 78.30%
2026
2027
2028

Current Ginkgo Bioworks Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
???
Locked
➜
Locked
Locked ???
Analyst Rating Date
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???
Locked
???:
Locked
➜
Locked
???

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today